1. Children of mothers with diabetes are more likely to develop cardiovascular disease.
Evidence Rating Level: 2 (Good)
The prevalence of cardiovascular disease (CVD) in children and young adults is increasing. Growing evidence suggests that maternal health during or before pregnancy may impact the development of CVD among offspring. Maternal diabetes is...
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
1. Obeticholic acid, a farnesoid X receptor agonist, prompts fibrosis improvement in patients with non-alcoholic steatohepatitis (NASH)
Evidence Rating Level: 1 (Excellent)
Non-alcoholic steatohepatitis (NASH) is an increasingly common cause of chronic liver disease...